Company / Working Capital per Share
Anika Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.65
FY2025
5-year range
$5.65 / $9.81
FY2021-FY2025
Trend
-8.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 3 consecutive years, from $9.81 in FY2022 to $5.65 in FY2025.
Based on SEC 10-K filings.
5.65 in FY2025 with a 5-year CAGR of -18.0%.
Declined from $9.04 to $5.65 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -16.8%
- 5-Year CAGR
- -18.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Anika Therapeutics, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 8.3% year-over-year.
- Peak working capital per share was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.65 | -8.3% |
| FY2024 | $6.16 | -31.8% |
| FY2023 | $9.04 | -7.8% |
| FY2022 | $9.81 | +1.3% |
| FY2021 | $9.68 | -36.5% |
| FY2020 | $15.24 | -0.7% |
| FY2019 | $15.34 | +17.6% |
| FY2018 | $13.05 | -1.2% |
| FY2017 | $13.21 | +22.9% |
| FY2016 | $10.75 | +0.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026